Back
Evoke Pharma Quote, Financials, Valuation and Earnings
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
13
EVOK
Evoke Pharma
Last Price:
4.56
Seasonality Move:
12.83%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Evoke Pharma Price Quote
$4.56
+0.26 (+6.05%)
(Updated: November 14, 2024 at 5:55 PM ET)
Evoke Pharma Key Stats
Sell
13
Evoke Pharma (EVOK)
is a Sell
Day range:
$4.03 - $5.02
52-week range:
$3.54 - $17.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.24
P/B ratio:
1.38%
Volume:
175.2K
Avg. volume:
785.4K
1-year change:
-71.33%
Market cap:
$3.7M
Revenue:
$5.2M
EPS:
$-26.4
How Much Does Evoke Pharma Make?
-
How Much Are Evoke Pharma's Sales Annually?
EVOK Revenues are $5.2M -
How Much Profit Does Evoke Pharma's Make A Year?
EVOK net income is -$7.8M
Is Evoke Pharma Growing As A Company?
-
What Is Evoke Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.26% -
What Is Evoke Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Evoke Pharma Stock Price Performance
-
Did Evoke Pharma Stock Go Up Last Month?
Evoke Pharma share price went down by -17.15% last month -
Did EVOK's Share Price Rise Over The Last Year?
EVOK share price fell by -71.33% over the past 1 year
What Is Evoke Pharma 52-Week High & Low?
-
What Is Evoke Pharma’s 52-Week High Share Price?
Evoke Pharma has traded as high as $17.88 over the past 52 weeks -
What Is Evoke Pharma’s 52-Week Low Share Price?
Evoke Pharma has traded as low as $3.54 over the past 52 weeks
Evoke Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Evoke Pharma?
-
How Much Debt Does Evoke Pharma Have?
Total long term debt quarterly is $5M -
How Much Cash Does Evoke Pharma Have?
Cash and short term investments quarterly total is $9.2M -
What Is Evoke Pharma’s Book Value Per Share?
Book value per share is 3.63
Is Evoke Pharma Cash Flow Positive?
-
What Is EVOK Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.5M -
What Is Evoke Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $7.7M -
What Is Evoke Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Evoke Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
EVOK return on invested capital is -115.56% -
What Is Evoke Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -67.32% -
What Is EVOK Return On Equity?
ROE is a measure of profitability and is -1005.23%
Evoke Pharma Earnings Date & Stock Price
-
What Is Evoke Pharma's Stock Price Today?
A single share of EVOK can be purchased today for 4.30 -
What Is Evoke Pharma’s Stock Symbol?
Evoke Pharma trades on the nasdaq under the ticker symbol: EVOK -
When Is Evoke Pharma’s Next Earnings Date?
The next quarterly earnings date for Evoke Pharma is scheduled on March 14, 2025 -
When Is EVOK's next ex-dividend date?
Evoke Pharma's next ex-dividend date is November 15, 2024 -
How To Buy Evoke Pharma Stock?
You can buy Evoke Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Evoke Pharma Competitors
-
Who Are Evoke Pharma's Competitors?
Below is a list of companies who compete with Evoke Pharma or are related in some way:
Evoke Pharma Dividend Yield
-
What Is EVOK Dividend Yield?
Evoke Pharma’s dividend yield currently is 0% -
What Is Evoke Pharma’s Payout Ratio?
Evoke Pharma’s payout ratio is 0% -
When Did Evoke Pharma Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Evoke Pharma’s Dividend Per Share?
Evoke Pharma pays a dividend of $0.00 per share
Evoke Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -147.37% |
| Revenue: | 125.51% | -20.96% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 18.00 |
| Upside from Last Price: | 318.6% |